Evidence map›Paper›PMID 42161585›Full record

ArticleGenome research2026

RECOMBINE identifies recurrent composite markers of cell types and states.

Xubin Li, Justin Nguyen, Anil Korkut

Abstract read
In one paragraph

Article in Genome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Xubin LiDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA akorkut@mdanderson.org xli27@mdanderson.org.
Justin NguyenDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Anil KorkutDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA akorkut@mdanderson.org xli27@mdanderson.org.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.U01CA253472 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORKUT, ANIL, LIANG, HAN · 2021 to 2025
$2.6M
NCI NIH HHS P30 CA016672NCI NIH HHS U01 CA253472
6 · The paper itself

Abstract

Biological function is mediated by the hierarchical organization of cell types and states within tissue ecosystems. Identifying interpretable composite marker sets that both define and distinguish hierarchical cell identities is essential for decoding biological complexity yet remains a major challenge. Here, we present RECOMBINE, an algorithm that identifies recurrent composite marker sets to define hierarchical cell identities. Validation using both simulated and biological data sets demonstrates that RECOMBINE is robust to hyperparameter variation and data sparsity, and achieves higher accuracy in identifying discriminant markers compared with existing approaches. As a partition-free framework, RECOMBINE is particularly powerful for data sets characterized by continuous cell-state transitions, in which defining discrete boundaries is inappropriate. This capability is demonstrated by its application to zebrafish development, revealing gradual transcriptional transitions across embryonic stages, and to the mouse cerebellum, in which it uncovers transcriptional variation shaped by spatial gradients. When applied to single-cell data and validated with spatial transcriptomic data from the mouse visual cortex, RECOMBINE identifies key cell-type markers and generates a robust gene panel for targeted spatial profiling. It also uncovers markers of CD8

Indexed as

AlgorithmsBiomarkersAnimalsCerebellumHumansMiceVisual CortexZebrafishBiomarkers

Identifiers

PMID42161585
PMCPMC13262949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.